Initiation of Inappropriate Antimicrobial Therapy Results in a Fivefold Reduction of Survival in Human Septic ShockAnand Kumar, Dan Château, David Simón et al.|CHEST Journal|2009Cited by 1.2k
Efficacy and Safety of Tifacogin (Recombinant Tissue Factor Pathway Inhibitor) in Severe SepsisEdward Abraham, Abla A. Creasey, Konrad Reinhart et al.|JAMA|2003Cited by 958
Early combination antibiotic therapy yields improved survival compared with monotherapy in septic shock: A propensity-matched analysis*Anand Kumar, Steve Doucette, Ryan Zarychanski et al.|Critical Care Medicine|2010Cited by 463
Guidance on patient Identification and Administration of Recombinant Human Activated protein C for the Treatment of Severe SepsisGary Garber, James A. Russell, R. T. Noel Gibney et al.|Canadian Journal of Infectious Diseases and Medical Microbiology|2002Cited by 13